Literature DB >> 28919423

COPS5 inhibition arrests the proliferation and growth of serous ovarian cancer cells via the elevation of p27 level.

Hongqin Zhang1, Ailing Zhong1, Jiajun Sun2, Miaomiao Chen1, Suhong Xie2, Hui Zheng2, Yanchun Wang2, Yiwen Yu2, Lin Guo1, Renquan Lu3.   

Abstract

The fifth component of the COP9 signalosome complex (COPS5), which plays an essential role in ubiquitin-mediated protein degradation, has been found as a prognostic biomarker for multiple cancers, however, the role of COPS5 in serous ovarian cancer (SOC) remain to be clarified. In this study, we found that COPS5 expression was significantly increased in SOC cells and tissues compared with those controls. Mechanistically, COPS5 and p27was proved to interact with each other, with COPS5 acts as a negative regulator of p27. SOC cells with COPS5 depletion were arrested in G1/G0-phase and exhibited a reduced proliferation ability and an increased cytoplasmic p27 expression. Whereas, the cells were stuck at S-phase accompanied with an elevation of nucleus p27 expression after knocking down COPS6 or blocking COPS5 by CSN5i-3. Furthermore, inhibition of COPS5 resulted in an elevation of Akt expression and sensitized SOC cells to Akt inhibitor MK2206. Suppression of COPS5 and Akt offers a potential strategy for the treatment of SOC.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Akt; COPS5; COPS6; Serous ovarian cancer; p27

Mesh:

Substances:

Year:  2017        PMID: 28919423     DOI: 10.1016/j.bbrc.2017.09.070

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Structural dynamics of the human COP9 signalosome revealed by cross-linking mass spectrometry and integrative modeling.

Authors:  Craig Gutierrez; Ilan E Chemmama; Haibin Mao; Clinton Yu; Ignacia Echeverria; Sarah A Block; Scott D Rychnovsky; Ning Zheng; Andrej Sali; Lan Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-07       Impact factor: 11.205

2.  CUL3 and COPS5 Related to the Ubiquitin-Proteasome Pathway Are Potential Genes for Muscle Atrophy in Mice.

Authors:  Qun Xu; Jinyou Li; Ji Yang; Zherong Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-30       Impact factor: 2.650

3.  Downregulation of XBP1 decreases serous ovarian cancer cell viability and enhances sensitivity to oxidative stress by increasing intracellular ROS levels.

Authors:  Gui Hong Zhang; Jin Yan Kai; Miao Miao Chen; Qian Ma; Ai Ling Zhong; Su Hong Xie; Hui Zheng; Yan Chun Wang; Ying Tong; Yuan Tian; Ren Quan Lu; Lin Guo
Journal:  Oncol Lett       Date:  2019-08-22       Impact factor: 2.967

4.  LncRNA PVT1 promotes tumorigenesis of glioblastoma by recruiting COPS5 to deubiquitinate and stabilize TRIM24.

Authors:  Tao Lv; Yichao Jin; Yifeng Miao; Tianqi Xu; Feng Jia; Haizhong Feng; Xiaohua Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-19       Impact factor: 8.886

5.  COPS5 Conferred the Platinum Resistance in Epithelial Ovarian Cancer.

Authors:  Hongqin Zhang; Tianqing Yan; Ailing Zhong; Lin Guo; Renquan Lu
Journal:  Curr Issues Mol Biol       Date:  2022-09-01       Impact factor: 2.976

6.  The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells.

Authors:  Huilin Zhang; Ping He; Qing Zhou; Yan Lu; Bingjian Lu
Journal:  Cancer Cell Int       Date:  2021-07-12       Impact factor: 5.722

7.  Inhibition of neddylation induces mitotic defects and alters MKLP1 accumulation at the midbody during cytokinesis.

Authors:  Dudley Chung; Jayme Salsman; Graham Dellaire
Journal:  Cell Cycle       Date:  2019-05-05       Impact factor: 4.534

8.  MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5.

Authors:  Balu Wu; Yunbao Pan; Guohong Liu; Tian Yang; Yanxia Jin; Fuling Zhou; Yongchang Wei
Journal:  Front Oncol       Date:  2019-11-07       Impact factor: 6.244

9.  Differential Expression of DUB Genes in Ovarian Cells Treated with Di-2-Ethylhexyl Phthalate.

Authors:  Da-Hye Lee; Jun-Hyeok Park; Jihye Choi; Kyung-Ju Lee; Bo-Seong Yun; Kwang-Hyun Baek
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.